Evidence map›Paper›PMID 34556243›Full record

ReviewDermatologic clinics2021

Cutaneous Pathology of COVID-19 as a Window into Immunologic Mechanisms of Disease.

Antonia E Gallman, Marlys S Fassett

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Dermatologic clinics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Antonia E GallmanDepartment of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA; Medical Scientist Training Program, University of California, San Francisco, 513 Parnassus Avenue, Room HSE1001A, San Francisco, CA 94143, USA.
Marlys S FassettDepartment of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA; Department of Dermatology, University of California, San Francisco, 513 Parnassus Avenue, Room HSE1001E, San Francisco, CA 94143, USA. Electronic address: marlys.fassett@ucsf.edu.
University of California, San Francisco · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007618 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANDERSON, MARK S · 1985 to 2020
$29.6M
Interleukin-31 at the neuroimmune interface of pruritus and dermatitisK08AR074556 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FASSETT, MARLYS S · 2019 to 2023
$887k
Dissecting the role of geranylgeranyl glutathione in the germinal center responseF30AI150061 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GALLMAN, ANTONIA · 2020 to 2022
$121k
NIAID NIH HHS F30 AI150061NIAMS NIH HHS K08 AR074556NIGMS NIH HHS T32 GM007618
6 · The paper itself

Abstract

Many skin manifestations of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection reflect activation of cutaneous and systemic immune responses involving effector pathways of both the innate and adaptive arms of the immune system. This article reviews evidence from the recent clinical and scientific literature that informs the current understanding of the consequences of coronavirus disease 2019 (COVID-19)-induced immune cell activation, as relevant to dermatology. Topics include the clinical consequences of autoantibody production in patients with COVID-19, immunologic evidence for chilblains as a manifestation of SARS-CoV-2 infection, and the relationship between type I interferons and COVID-19 disease severity.

Indexed as

ChilblainsCOVID-19Erythema MultiformeExanthemaHumansPityriasis RoseaSkinSkin DiseasesSkin Diseases, VesiculobullousAutoantibodyChilblainsCOVID-19ImmunologyLivedoSARS-CoV-2Type I interferon

Identifiers

PMID34556243
PMCPMC8297957
OpenAlexW3187007473

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.